期刊文献+

免疫固定电泳联合轻链检测在多发性骨髓瘤中的临床应用 被引量:2

Clinical Application of Immunofixtion Electrophpresis and Light Chain Analysis in Multiple Myeloma
下载PDF
导出
摘要 目的探讨血清免疫固定电泳(immunofixtion electrophpresis,IFE)联合轻链检测在多发性骨髓瘤(multiple myeloma,MM)诊断中的意义。方法收集2016年3月至2016年7月在南京医科大学第一附属医院就诊的MM患者120例以及同期健康体检者30例,对MM患者血清进行IFE和轻链定量检测,各组间的比较采用t检验。结果 120例MM患者有115例IFE检出M带,检出率为95.83%,其中以IgG型最多(61.67%),IgA型(26.66%)和轻链型(2.50%)次之,IgM型(1.67%)较少见。轻链检测结果显示,κ/λ比值在MM的各种免疫分型中差异均有统计学意义(P<0.05)。结论 IFE和轻链检测对MM的诊疗具有重要临床应用价值。 Objective To evaluate the diagnostic significance of immunofixtion electrophpresis (IFE) and light chain analysis in multiple myeloma(MM). Methods We selected 120 MM patients as study group and 30 healthy subjects as control group from the First Affiliated Hospital of Nanjing Medical University. IFE and light chain test were performed on serum samples of these patients. T test was used for the statistical analysis. Results M protein was positive in 115 cases (95.83%) among 120 MM patients by using IFE. IgG were the most type of the M protein (61.67%), and IgA type (26.66%), light chain (2.50%) and IgM type (1.67%). Light chain test showed that the ratio of κ/λ was significantly abnormal in different types of MM (P〈0.05). Conclusion IFE and light chain test have great clinical value in the diagnosis and treatment of MM.
作者 王加 王珏
出处 《标记免疫分析与临床》 CAS 2017年第10期1088-1090,共3页 Labeled Immunoassays and Clinical Medicine
基金 江苏省实验诊断学重点实验室基金(XK 201114)
关键词 多发性骨髓瘤 免疫固定电泳 κ/λ比值 Multiple myeloma Immunofixtion electrophpresis κ/λratio
  • 相关文献

参考文献3

二级参考文献22

  • 1李华,翟锬.血清κ/λ轻链比值测定对多发性骨髓瘤的诊断价值[J].国际检验医学杂志,2006,27(2):100-101. 被引量:9
  • 2颜向军,谢海涛.免疫固定电泳技术对多发性骨髓瘤的分型鉴定[J].南华大学学报(医学版),2007,35(1):107-109. 被引量:4
  • 3陈协群,张永清.多发性骨髓瘤的诊断与疗效标准[J].国际输血及血液学杂志,2007,30(4):297-299. 被引量:8
  • 4Hussein MA,Juturi V,Lieberman I.Multiple mydoma:present and future[J].Curt Opin Oncol,2002,14(1):3l-35.
  • 5International Mydoma Working Group.Criteria for the classification of monoclonal gammopathies,multiple mydoma an d related disorders:a report of the International Myema Woing Group[J].Br J Haematol,2003,121(5):749-757.
  • 6Hussein MA,Juturi JV,Lieberman I.Multiple myeloma:present and future[J].Curr Opin Oncol,2002,14(1):31.
  • 7Dierlamm T,Laack E,Dierlamm J,et al.IgM myeloma:a report of four cases[J].Ann Hematol,2002,81(3):136-139.
  • 8Katzmann JA,Clark RJ,Abraham RS,et al.Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains:relative sensitivity for detection of monoclonal light chains[J].Clin Chem,2002,48(9):1437-1444.
  • 9Piehler AP,Gulbrandsen N,Kierulf P,et al.Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population[J].Clin Chem,2008,54(11):1823-1830.
  • 10Bradwell AR,Carr-Smith HD,Mead GP,et al.Serum test for assessment of patients with Bence Jones myeloma[J].Lancet,2003,361 (9356):489-491.

共引文献21

同被引文献16

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部